Go to Live Updates
Q2 Earnings 2024 Live Updates: While major companies across sectors have already released their Q2 numbers for FY25, market participants and investors are keenly waiting for many others to announce their earnings report. Firms including Tata Consultancy Services (TCS), HCL Technologies, Infosys, Wipro, Tech Mahindra, Reliance Industries, Mahindra and Mahindra, Bharti Airtel, HUL, ITC, Marico, Dabur India, Adani Wilmar, Nestle India, BHEL, L&T, Adani Enterprises, Apollo Hospitals, Mankind Pharma, Dr Reddy’s Laboratories, GAIL, Punjab National Bank, Axis Bank, HDFC Bank, IRCTC, Coal India, JK Lakshmi Cement, Havells India, Paytm, ABFRL, Zomato, PVR Inox, Lupin, Piramal Pharma, among many others have announced their Q2 reports.
Today, companies like State Bank of India, Life Insurance Corporation of India, Tata Motors, Vedanta, Power Finance Corporation, Info Edge India, Ashok Leyland, MRF, Premier Energies, Fortis Healthcare, Ola Electric Mobility, Whirlpool of India, Welspun Corp, SignatureGlobal India, Relaxo Footwears, India Cements, Metropolis Healthcare, Mrs. Bectors Food Specialities, Inox India, Puravankara, Shipping Corporation of India, Star Cement, Ethos, Orient Cement, Khadim India Limited, VIP Clothing, Noida Toll Bridge Company, among others are lined up to release their Q2 earnings report.
Till date, the corporate earnings scorecard for Q2FY25 has been weak but excluding commodities, it’s broadly in-line. According to areport by Motilal Oswal Financial Services (MOFSL), “The earnings spread has deteriorated, with only 62 per cent of MOFSL Coverage Universe either meeting or exceeding profit expectations. Consumption has emerged as a weak spot while select segments of BFSI are seeing asset-quality stress. Nifty FY25 EPS has seen another 1 per cent cut after a 4 per cent cut in preview. Overall Nifty EPS has seen 7 per cent downward revision in the last six months, reducing the expected FY25 earnings growth to just 5 per cent, weakest since FY20.”
Also Read MSCI Index review on November 06: Alkem Lab, Voltas, Oberoi Realty, Adani Energy Solutions, BSE, other stocks may benefit Q2 Result 2024: Titan Company, GAIL, Mankind Pharma, Dr Reddy’s, Berger Paints, others releasing Q2 results today What to watch for trade on November 05? Focus on NSE, Gland Pharma, Bharti Airtel and NTPC Q2 Result 2024: IRCTC, Exide Industries, Gland Pharma, Bata India, Raymond, P&G Health, others releasing Q2 results today
India Inc is also under scanner as the country is watching its performance in the previous quarter and also the impact of the recent victory of Donald Trump in the US presidential election on the performance during the ongoing quarter and fiscal year.
» Read More